Storm clouds gather over U.S. stocks as hopes of quick recovery fade
A lightning-quick rally in U.S. equities is showing cracks, as investors face mounting evidence that the economy’s coronavirus-fueled woes may be far longer-lasting than many...
U.S. Senator’s phone seized in probe of stock trades after virus briefings – LA Times
U.S. Senator Richard Burr has had his cellphone seized by federal agents as part of the Justice Department’s probe of stock transactions made by the...
Clariant sticks to extra $1 billion payout, scrubs dividend in crisis
Clariant is scrapping a regular dividend as it hunkers down to survive the COVID-19 crisis, the Swiss specialty chemicals maker said on Thursday, while still...
Digicel Group denies report of Pacific unit sale to China Mobile
Jamaica-based mobile phone carrier Digicel Group denied an Australian newspaper report on Thursday and said there is “no basis whatsoever” that it would sell its...
Truck bomb in eastern Afghan city kills five, 14 injured
A truck packed with explosives blew up near a court in the eastern Afghan city of Gardez on Thursday, killing at least five people, two...
Coronavirus brings curtain down on Cambodia shadow puppet theatre
Cambodia’s shadow puppet tradition goes back to the 7th century and has survived the collapse of empires, wars and Khmer Rouge reign of terror that...
Dolce & Gabbana will lose out from virus crisis, founders tell paper
Italian fashion group Dolce & Gabbana will lose out “a lot” this year, after the coronavirus emergency, founders Domenico Dolce and Stefano Gabbana said on...
Chip specialist AT&S’s full-year core profit down 22% on expansion cost
Printed circuit boards maker AT&S said on Thursday that core profit and revenue in its current first quarter were on the previous year’s level after...
‘We feel like guests’: Manila cruise flotilla offers crew confinement in comfort
(This May 11 story corrects paragraph 2 to show figure is interior volume, not weight)...
Sanofi gets priority U.S. FDA review for sutimlimab product
French healthcare company Sanofi said on Thursday that the U.S. Food & Drug Administration (FDA) regulator had granted a priority review for Sanofi’s sutimlimab product,...